Category: Biotechnology
Global Biotechnology
-
Real-time PCR (qPCR) and Digital PCR (dPCR)
... US$5.6 Billion in the year 2023, is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Quantitative Technology, one of the segments analyzed in the report, ... Read More
-
Tissue Engineering
... at a CAGR of 12.5% over the analysis period 2023-2030. Orthopedics, Musculoskeletal & Spine Application, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by ... Read More
-
The Global Market for Industrial Biomanufacturing 2025-2035
... pharmaceutical industries. Products are isolated from natural sources, such as blood, cultures of microbes, animal cells, or plant cells grown in specialized equipment or dedicated cultivation environments. The cells/tissues or enzymes used may be natural ... Read More
-
Biotechnology
... of 8.4% over the analysis period 2023-2030. DNA Sequencing Market, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis ... Read More
-
Interferon
... of 2.7% over the analysis period 2023-2030. Interferon Beta, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Exosome Research Products
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$697.8 Million ... Read More
-
Seeds Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global seeds market by segmenting the market based on type, seed type, trait, ... Read More
-
Atomic Force Microscopy
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Industrial Grade Atomic Force Microscopy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More
-
Protein Sequencing
... at a CAGR of 2.9% over the analysis period 2023-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end ... Read More
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Biochemical Reagents
... at a CAGR of 8.7% over the analysis period 2023-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$6.3 Billion by the end ... Read More
-
Biopharmaceutical Logistics
... at a CAGR of 4.8% over the analysis period 2023-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$37.9 Billion by the end ... Read More
-
Biopharmaceutical Fermentation Systems
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... Kits and Analytical Instruments estimated at US$79.0 Billion in the year 2023, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Biochips & Microarrays, one ... Read More
-
Allografts
... of 6.8% over the analysis period 2023-2030. Demineralized Bone Matrix (DBM), one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$488.4 Million by the end of the ... Read More
-
Antibody Production
... at a CAGR of 10.5% over the analysis period 2023-2030. Monoclonal Antibody, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$27.4 Billion by the end of ... Read More
-
Flow Imaging Microscopy/Dynamic Image Analysis
... is expected to reach US$70.8 Million by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Biologics Sample, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Molecular Breeding
... at a CAGR of 17.5% over the analysis period 2023-2030. Marker-Assisted Selection (MAS) Process, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$11.7 Billion by the ... Read More
-
Food Enzymes
... at a CAGR of 6.0% over the analysis period 2023-2030. Microorganisms Source, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.6 Billion by the end of ... Read More
-
Diagnostic Specialty Enzymes
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million ... Read More
-
Plant Cell Culture Equipment
... reach US$2.6 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$784.8 ... Read More
-
Process Spectroscopy
... at a CAGR of 6.6% over the analysis period 2023-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$26.2 Billion by the end of ... Read More
-
Fucoxanthin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... million by 2030 with a CAGR of 4.77% during the forecast period 2024-2030. North American market for Fucoxanthin was valued at $ 13.54 million in 2023 and will reach $ 19.34 million by 2030, at ... Read More
-
Single-Cell Genome Sequencing
... by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Cell Genome Sequencing Instruments, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$4.5 ... Read More
-
Aerospace & Life Sciences Testing, Inspection, and Certification
... Certification estimated at US$36.2 Billion in the year 2023, is expected to reach US$48.4 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. In-House Testing, Inspection, and Certification, one of ... Read More
Research Assistance
